Sanofi
SNY
$48.66
$0.310.64%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -356.99% | -- | -- | -- | |
| Total Depreciation and Amortization | 24.48% | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -82.90% | -- | -- | -- | |
| Change in Net Operating Assets | -- | -- | -- | -- | |
| Cash from Operations | 3.19% | -- | -- | -- | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 400.87% | -- | -- | -- | |
| Cash from Investing | -496.82% | -- | -- | -- | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 214.50% | -- | -- | -- | |
| Cash from Financing | 27.87% | -- | -- | -- | |
| Foreign Exchange rate Adjustments | -48.51% | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -73.23% | -- | -- | -- | |